Table 1.
Baseline characteristics (mean±SD) of the diabetic patients at initiation of the intervention
| Characteristic | Test product (n=19) |
Placebo (n=17) |
|---|---|---|
| Age (years) | 65.0±6.0 | 61.9±7.6 |
| BMI (kg/m2) | 30.9±4.0 | 30.0±5.5 |
| Gender (female/male) | 12/7 | 6/11 |
| Duration of diabetes (years) | 12.4±8.0 | 9.1±6.5 |
| Fasting blood glucose (mmol/l) | 141.5±37.3 | 125.2±19.8 |
| HbA1c (%) | 7.3±0.9 | 7.2±0.6 |
| Fructosamine (µmol/l) | 284.3±33.1 | 267.2±33.1 |
| Cholesterol (mg/dl) | 198.0±45.2 | 206.7±36.7 |
| LDL (mg/dl) | 111.8±39.9 | 117.4±33.8 |
| HDL (mg/dl) | 53.8±13.8 | 48.6±14.0 |
| Triglycerides (mg/dl) | 192.9±124.1 | 202.3±103.4 |
| Uric acid (mg/dl) | 5.8±1.6 | 6.3±1.6 |
| GOT (U/l) | 29.6±7.5 | 27.2±7.7 |
| GPT (U/l) | 31.0±11.0 | 27.2±11.1 |
| Gamma-GT (U/l) | 52.0±49.6 | 41.6±32.0 |